Suppr超能文献

通过 CRISPR 激活靶向转录上调 SENP1,增强去 SUMOylation 途径,在神经病理性疼痛的脊神经结扎模型中产生镇痛作用。

Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.

机构信息

Department of Molecular Pathobiology, College of Dentistry, New York University, New York, NY, United States.

NYU Pain Research Center, New York, NY, United States.

出版信息

Pain. 2024 Apr 1;165(4):866-883. doi: 10.1097/j.pain.0000000000003080. Epub 2023 Oct 20.

Abstract

The voltage-gated sodium channel Na V 1.7 is an essential component of human pain signaling. Changes in Na V 1.7 trafficking are considered critical in the development of neuropathic pain. SUMOylation of collapsin response mediator protein 2 (CRMP2) regulates the membrane trafficking and function of Na V 1.7. Enhanced CRMP2 SUMOylation in neuropathic pain correlates with increased Na V 1.7 activity. Pharmacological and genetic interventions that interfere with CRMP2 SUMOylation in rodents with neuropathic pain have been shown to reverse mechanical allodynia. Sentrin or SUMO-specific proteases (SENPs) are vital for balancing SUMOylation and deSUMOylation of substrates. Overexpression of SENP1 and/or SENP2 in CRMP2-expressing cells results in increased deSUMOylation and decreased membrane expression and currents of Na V 1.7. Although SENP1 is present in the spinal cord and dorsal root ganglia, its role in regulating Na V 1.7 function and pain is not known. We hypothesized that favoring SENP1 expression can enhance CRMP2 deSUMOylation to modulate Na V 1.7 channels. In this study, we used a clustered regularly interspaced short palindromic repeats activation (CRISPRa) SENP1 lentivirus to overexpress SENP1 in dorsal root ganglia neurons. We found that SENP1 lentivirus reduced CRMP2 SUMOylation, Na V 1.7-CRMP2 interaction, and Na V 1.7 membrane expression. SENP1 overexpression decreased Na V 1.7 currents through clathrin-mediated endocytosis, directly linked to CRMP2 deSUMOylation. Moreover, enhancing SENP1 expression did not affect the activity of TRPV1 channels or voltage-gated calcium and potassium channels. Intrathecal injection of CRISPRa SENP1 lentivirus reversed mechanical allodynia in male and female rats with spinal nerve injury. These results provide evidence that the pain-regulating effects of SENP1 overexpression involve, in part, the modulation of Na V 1.7 channels through the indirect mechanism of CRMP2 deSUMOylation.

摘要

电压门控钠离子通道 NaV1.7 是人类疼痛信号传导的重要组成部分。NaV1.7 运输的变化被认为是神经性疼痛发展的关键。 collapsin 反应介体蛋白 2 (CRMP2) 的 SUMO 化调节 NaV1.7 的膜运输和功能。神经病理性疼痛中增强的 CRMP2 SUMO 化与 NaV1.7 活性增加相关。在患有神经病理性疼痛的啮齿动物中,干扰 CRMP2 SUMO 化的药理学和遗传学干预已被证明可以逆转机械性痛觉过敏。Sentrin 或 SUMO 特异性蛋白酶 (SENP) 对于平衡底物的 SUMO 化和去 SUMO 化至关重要。在表达 CRMP2 的细胞中过表达 SENP1 和/或 SENP2 会导致去 SUMO 化增加,膜表达和 NaV1.7 电流减少。尽管 SENP1 存在于脊髓和背根神经节中,但它在调节 NaV1.7 功能和疼痛中的作用尚不清楚。我们假设促进 SENP1 表达可以增强 CRMP2 的去 SUMO 化作用,从而调节 NaV1.7 通道。在这项研究中,我们使用聚类规则间隔短回文重复激活 (CRISPRa) SENP1 慢病毒在背根神经节神经元中过表达 SENP1。我们发现 SENP1 慢病毒减少了 CRMP2 SUMO 化、NaV1.7-CRMP2 相互作用和 NaV1.7 膜表达。SENP1 过表达通过网格蛋白介导的内吞作用降低了 NaV1.7 电流,这与 CRMP2 的去 SUMO 化直接相关。此外,增强 SENP1 表达不会影响 TRPV1 通道或电压门控钙和钾通道的活性。鞘内注射 CRISPRa SENP1 慢病毒逆转了脊髓神经损伤雄性和雌性大鼠的机械性痛觉过敏。这些结果提供了证据,表明 SENP1 过表达的疼痛调节作用部分涉及通过 CRMP2 去 SUMO 化的间接机制调节 NaV1.7 通道。

相似文献

2
CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.CRMP2 蛋白 SUMOylation 调节 NaV1.7 通道运输。
J Biol Chem. 2013 Aug 23;288(34):24316-31. doi: 10.1074/jbc.M113.474924. Epub 2013 Jul 8.

本文引用的文献

2
Structural Basis for the SUMO2 Isoform Specificity of SENP7.SENP7 的 SUMO2 同种型特异性的结构基础。
J Mol Biol. 2022 Dec 30;434(24):167875. doi: 10.1016/j.jmb.2022.167875. Epub 2022 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验